| SLONIN JONATHAN | Chief Medical Officer | 3,040Common Stock | — | Sell | |
|---|
| RIKER LAUREN | Senior Vice President, Finance | 6,115Common Stock | — | Sell | |
|---|
| Brege Laura | Director | 10,891Stock Option (Right to Buy) | — | Grant / award | |
|---|
| Brege Laura | Director | 6,405Common Stock | — | Grant / award | |
|---|
| Froimson Mark | Director | 10,891Stock Option (Right to Buy) | — | Grant / award | |
|---|
| Froimson Mark | Director | 6,405Common Stock | — | Grant / award | |
|---|
| BIGAL MARCELO | Director | 10,891Stock Option (Right to Buy) | — | Grant / award | |
|---|
| BIGAL MARCELO | Director | 6,405Common Stock | — | Grant / award | |
|---|
| YANG MICHAEL J. | Director | 10,891Stock Option (Right to Buy) | — | Grant / award | |
|---|
| YANG MICHAEL J. | Director | 6,405Common Stock | — | Grant / award | |
|---|
